Abbott Acquires Cardiovascular Systems, Inc.
February 8, 2023
Abbott has agreed to acquire Cardiovascular Systems, Inc. (CSI) for $20.00 per share, representing an expected equity value of approximately $890 million. The acquisition adds CSI's orbital atherectomy system and early-stage vascular intervention pipeline to Abbott's vascular device portfolio to expand its capabilities in treating peripheral and coronary artery disease.
- Buyers
- Abbott
- Targets
- Cardiovascular Systems, Inc.
- Sellers
- Cardiovascular Systems, Inc. stockholders
- Industry
- Medical Devices
- Location
- Minnesota, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Circle Cardiovascular Imaging Acquires Corstem Inc.
February 7, 2019
Healthcare Services
Circle Cardiovascular Imaging Inc. has acquired Montreal-based AI cardiac imaging developer Corstem Inc. Corstem’s automatic, fully-quantitative myocardial perfusion technology will be integrated into Circle’s cvi42 platform to expand its cardiac MRI perfusion capabilities and accelerate global clinical deployment.
-
Haemonetics Acquires Cardiva Medical
January 20, 2021
Medical Devices
Haemonetics Corporation agreed to acquire Cardiva Medical, Inc., a privately-held maker of vascular closure systems based in Santa Clara, California, for $475 million upfront and up to $35 million in contingent consideration. The acquisition expands Haemonetics' hospital portfolio and its presence in the interventional cardiology and electrophysiology markets and is expected to be accretive to revenue growth.
-
Keystone Heart Acquires 510 Kardiac Devices, Inc.
June 16, 2020
Medical Devices
Keystone Heart Ltd., a Venus Medtech company, has acquired 510 Kardiac Devices, Inc., the developer of the Lim Transseptal System. The acquisition expands Keystone Heart's structural heart portfolio by adding a transseptal access system designed for left-sided structural heart and electrophysiology procedures and will support commercial introduction in the US and Europe.
-
Johnson & Johnson Acquires Abiomed
December 22, 2022
Medical Devices
Johnson & Johnson completed its acquisition of Abiomed on December 22, 2022, acquiring all outstanding shares for $380.00 per share (approximately $16.6 billion enterprise value) plus a contingent value right. Abiomed will operate as a standalone business within Johnson & Johnson's MedTech segment, expanding J&J's capabilities in high-growth cardiovascular and heart-recovery solutions.
-
Philips Acquires Intact Vascular
August 27, 2020
Medical Devices
Royal Philips has signed an agreement to acquire Intact Vascular, a U.S.-based developer of the Tack Endovascular System, to expand Philips' image-guided therapy devices portfolio for peripheral artery disease. The deal includes USD 275 million upfront in cash plus deferred payments (up to ~USD 360 million total) and is expected to close in the third quarter of 2020, after which Intact Vascular will join Philips' Image-Guided Therapy business.
-
Centerbridge and Bridgeport Acquire Computer Services, Inc. for $1.6 Billion
November 16, 2022
Cloud & SaaS
Private equity firms Centerbridge Partners and Bridgeport Partners completed an all-cash $1.6 billion acquisition of Computer Services, Inc. (CSI), taking the company private at $58.00 per share and causing its common stock to cease trading on the OTCQX. The deal positions CSI to accelerate investment in cloud, R&D, and expanded fintech/regtech product capabilities to better serve community banks, fintechs and corporate customers.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.